Using GM-CSF as a Host Directed Therapeutic against COVID-19 - A Phase 2 Investigator Initiated Trial
- Funded by National Medical Research Council Singapore
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
National Medical Research Council SingaporePrincipal Investigator
A/Prof. Jenny LowResearch Location
SingaporeLead Research Institution
SGH SingaporeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified